IBRX
ImmunityBio Inc.
Company Overview
| Mkt Cap | $2.44B | Price | $2.40 |
| Volume | 6.81M | Change | +1.69% |
| P/E Ratio | -5.9 | Open | $2.37 |
| Revenue | $14.7M | Prev Close | $2.36 |
| Net Income | $-413.6M | 52W Range | $1.83 - $5.88 |
| Div Yield | N/A | Target | $10.20 |
| Overall | 32 | Value | 40 |
| Quality | 39 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyImmunityBio Inc. (IBRX) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $2.40 with a market capitalization of $2.44 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows IBRX with a volume of 6.81 million shares. The stock opened up 0.42% from yesterday's close of $2.36. Current analyst estimates project earnings of $-0.46 per share for this year, with next year targeting $-0.37.
IBRX demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IBRX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 325.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 10:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $2.40 | +1.7% | 6.81M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |